Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes.
Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes.
复制标题
DOI:
10.2337/db15-0627
复制
发表时间:
2016-01
期刊:
影响因子:
7.7
通讯作者:
Neubauer S
中科院分区:
文献类型:
--
作者:
Levelt E;Mahmod M;Piechnik SK;Ariga R;Francis JM;Rodgers CT;Clarke WT;Sabharwal N;Schneider JE;Karamitsos TD;Clarke K;Rider OJ;Neubauer S
Concentric left ventricular (LV) remodelling is associated with adverse cardiovascular events and is frequently observed in patients with type 2 diabetes mellitus (T2DM). Despite this, the cause of concentric remodelling in diabetes, per se, is unclear, but may be related to cardiac steatosis and impaired myocardial energetics. Thus, we investigated the relationship amongst myocardial metabolic changes and LV remodelling in T2DM. Forty-six non-hypertensive T2DM patients and twenty matched controls underwent cardiovascular magnetic resonance to assess LV remodelling (LV mass to LV end diastolic volume ratio-LVMVR), function, pre- and post-contrast tissue characterisation using T1 mapping, 1H-, 31P-magnetic resonance spectroscopy for myocardial triglyceride content (MTG) and phosphocreatine to ATP ratio (PCr/ATP) respectively. When compared to body mass index and blood pressure matched controls, diabetes was associated with: concentric LV remodelling, higher MTG, impaired myocardial energetics and impaired systolic strain indicating a subtle contractile dysfunction. Importantly, cardiac steatosis independently predicted concentric remodelling and systolic strain. Extracellular volume fraction was unchanged, indicating absence of fibrosis. In conclusion, cardiac steatosis may contribute to LV concentric remodelling and contractile dysfunction in diabetes. As cardiac steatosis is modifiable, strategies aimed at reducing myocardial triglyceride may be beneficial in reversing concentric remodelling and improving contractile function in the diabetic heart.